BlackRock Inc. - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 171 filers reported holding BRIDGEBIO PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$243,920,998
+48.0%
9,249,943
-3.5%
0.01%
+40.0%
Q2 2023$164,805,738
+9.0%
9,581,729
+5.1%
0.01%
+25.0%
Q1 2023$151,172,809
+103.1%
9,117,781
-6.7%
0.00%
+100.0%
Q4 2022$74,433,616
-19.2%
9,768,191
+5.4%
0.00%
-33.3%
Q3 2022$92,103,000
+8.4%
9,265,868
-1.0%
0.00%0.0%
Q2 2022$84,976,000
-8.4%
9,358,581
+2.3%
0.00%0.0%
Q1 2022$92,815,000
-40.0%
9,144,207
-1.4%
0.00%
-25.0%
Q4 2021$154,717,000
-67.5%
9,275,590
-8.5%
0.00%
-69.2%
Q3 2021$475,323,000
-17.9%
10,141,311
+6.7%
0.01%
-18.8%
Q2 2021$579,140,000
+3.6%
9,500,321
+4.7%
0.02%0.0%
Q1 2021$558,874,000
+20.6%
9,072,637
+39.2%
0.02%
+6.7%
Q4 2020$463,464,000
+101.8%
6,517,544
+6.5%
0.02%
+87.5%
Q3 2020$229,627,000
+26.7%
6,120,137
+10.1%
0.01%
+14.3%
Q2 2020$181,263,000
+19.7%
5,558,486
+6.4%
0.01%0.0%
Q1 2020$151,457,000
+62.5%
5,222,598
+96.4%
0.01%
+75.0%
Q4 2019$93,223,000
+194.4%
2,659,723
+80.3%
0.00%
+300.0%
Q3 2019$31,663,000
+2095.8%
1,474,772
+2656.6%
0.00%
Q2 2019$1,442,00053,5000.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders